IL157321A0 - Acrochordon alleviation - Google Patents

Acrochordon alleviation

Info

Publication number
IL157321A0
IL157321A0 IL15732103A IL15732103A IL157321A0 IL 157321 A0 IL157321 A0 IL 157321A0 IL 15732103 A IL15732103 A IL 15732103A IL 15732103 A IL15732103 A IL 15732103A IL 157321 A0 IL157321 A0 IL 157321A0
Authority
IL
Israel
Prior art keywords
acrochordon
pigmentation
alleviation
acrochordon removal
removal
Prior art date
Application number
IL15732103A
Other languages
English (en)
Original Assignee
Physician S Choice Of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Physician S Choice Of Arizona filed Critical Physician S Choice Of Arizona
Publication of IL157321A0 publication Critical patent/IL157321A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
IL15732103A 2001-02-09 2003-02-08 Acrochordon alleviation IL157321A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26797801P 2001-02-09 2001-02-09
PCT/US2002/003530 WO2002064151A1 (fr) 2001-02-09 2002-02-08 Traitement des acrochordons

Publications (1)

Publication Number Publication Date
IL157321A0 true IL157321A0 (en) 2004-02-19

Family

ID=23020931

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15732103A IL157321A0 (en) 2001-02-09 2003-02-08 Acrochordon alleviation

Country Status (13)

Country Link
US (1) US7138146B2 (fr)
EP (1) EP1365781B1 (fr)
JP (1) JP2004518715A (fr)
CN (1) CN100508990C (fr)
AT (1) ATE397452T1 (fr)
BR (1) BR0207163A (fr)
CA (1) CA2437823A1 (fr)
DE (1) DE60226953D1 (fr)
IL (1) IL157321A0 (fr)
MX (1) MXPA03007151A (fr)
NZ (1) NZ527673A (fr)
SG (1) SG167656A1 (fr)
WO (1) WO2002064151A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852832B1 (fr) 2003-03-25 2008-06-27 Oreal Composition de coloration pour fibres keratiniques comprenant un acide hydroxycarboxilique ou un sel, composition prete a l'emploi la comprenant, procede de mise en oeuvre et dispositif
US8257780B2 (en) 2003-10-31 2012-09-04 Resource Development L.L.C. Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using
KR20060004399A (ko) * 2004-07-09 2006-01-12 에스케이케미칼주식회사 자기발열체를 이용한 케토프로펜의 경피투여 시스템
WO2006085302A2 (fr) * 2005-02-08 2006-08-17 Bmz Diagnosis (2004) Ltd. Composition pour traiter des troubles de peau
FR2947452B1 (fr) * 2009-07-01 2012-04-20 Fabre Pierre Dermo Cosmetique L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
JP5431501B2 (ja) * 2010-01-13 2014-03-05 株式会社東芝 画像処理装置、及びその方法
WO2012177799A1 (fr) * 2011-06-20 2012-12-27 Atheronova Operations, Inc. Réduction de la graisse sous-cutanée
EP3134061B1 (fr) * 2014-04-21 2020-10-07 Aclaris Therapeutics, Inc. Formules de peroxyde et procédés et applicateurs pour leur utilisation
JP6543091B2 (ja) * 2014-06-03 2019-07-10 御木本製薬株式会社 Ｐｍｅｌ１７遺伝子発現抑制剤
CN105557691B (zh) * 2015-12-31 2018-07-20 中国检验检疫科学研究院 一种枣实蝇引诱剂及其应用
CN108459157B (zh) * 2018-01-11 2020-11-27 中国药科大学 一种预测伊立替康化疗毒性生物标志物的组合物
CN110898076A (zh) * 2019-12-12 2020-03-24 刘贤贤 一种去除角质的药物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954974A (en) 1972-06-09 1976-05-04 Paul Herzog Disinfectant for the surface of human body parts containing hydrogen peroxide
US4018802A (en) 1975-04-09 1977-04-19 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes
US4128564A (en) 1976-03-22 1978-12-05 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins
US4485091A (en) 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4438102A (en) 1982-08-10 1984-03-20 Ciro's Touch, Ltd. Method of promoting tissue growth
LU85789A1 (fr) * 1985-02-26 1986-09-02 Oreal Utilisation dans les domaines therapeutique et cosmetique d'une solution anhydre de peroxyde d'hydrogene
US5380764A (en) * 1989-06-08 1995-01-10 Herzog; Paul Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use
GB9007762D0 (en) 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
JPH04159229A (ja) * 1990-09-14 1992-06-02 Senju Pharmaceut Co Ltd 真珠腫治療剤
JPH06206825A (ja) 1992-12-11 1994-07-26 Nippon Rooshiyon Kk 白癬菌、湿疹等による皮膚病の治療剤及び 皮膚殺菌活性化剤
GB2285218A (en) 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
US5594015A (en) 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
US5736582A (en) 1996-10-10 1998-04-07 Devillez; Richard L. Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US5958984A (en) * 1996-10-10 1999-09-28 Devillez; Richard L. Method and composition for skin treatment
US6028104A (en) 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
US6146640A (en) 1998-08-31 2000-11-14 Dyke; John Paul Immune system catalyst

Also Published As

Publication number Publication date
WO2002064151A1 (fr) 2002-08-22
NZ527673A (en) 2005-03-24
EP1365781B1 (fr) 2008-06-04
DE60226953D1 (de) 2008-07-17
BR0207163A (pt) 2004-06-29
CN1501804A (zh) 2004-06-02
CA2437823A1 (fr) 2002-08-22
EP1365781A1 (fr) 2003-12-03
US7138146B2 (en) 2006-11-21
MXPA03007151A (es) 2004-10-15
CN100508990C (zh) 2009-07-08
US20030008018A1 (en) 2003-01-09
ATE397452T1 (de) 2008-06-15
SG167656A1 (en) 2011-01-28
EP1365781A4 (fr) 2005-01-12
JP2004518715A (ja) 2004-06-24

Similar Documents

Publication Publication Date Title
IL157321A0 (en) Acrochordon alleviation
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
NO20023267L (no) Behandling av kongestiv hjertefeil ved forbehandlet autologt blod
WO2002034072A3 (fr) Combinaison antioxydante synergistique de tocols delta et de polyphenols
MXPA03007856A (es) Derivado de geldanamicina y metodo de usarlo para tratar cancer.
EP1401479A4 (fr) Detection et therapie de plaques vulnerables a l'aide de composes photodynamiques
GB2366179B (en) Antioxidant compositions and methods for companion animals
WO2003045494A3 (fr) Therapies faisant appel a l'imiquimod
WO2005000211A3 (fr) Methode de traitement de maladies mettant en oeuvre des agents inhibant hsp90 conjointement avec des complexes de coordination du platine
EA200101089A1 (ru) Новый способ лечения
NO20041598L (no) Fremgangsmater for behandling eller profylakse av vaskulaer betennelse ved anvendelse av sterolabsorpsjonsinhibitor(er)
EP1628667A4 (fr) Methode permettant de traiter des maladies a l'aide d'agents d'inhibition hsp90 combines a des antimitotiques
WO2003024386A8 (fr) Utilisation d'inhibiteurs c-kit puissants, selectifs et non toxiques pour le traitement de la cystopathie interstitielle sous-muqueuse
EP1631267A4 (fr) Methode de traitement de maladies mettant en oeuvre des agents inhibant hsp90 conjointement avec des antimetabolites
WO2004093995A3 (fr) Utilisation d'antioxydants pour traiter les troubles associes a la perte osseuse
WO2004017917A3 (fr) Procede pour la prevention et/ou le traitement de l'atherosclerose
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
CA2408541A1 (fr) Traitement contre l'eczema et/ou le psoriasis
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
WO2005020908A3 (fr) Inhibiteurs selectifs d'activation de stat-3 et utilisations associees
WO2003049674A3 (fr) Methode de traitement de virus enveloppes faisant appel a des esters d'huile de jojoba
CZ20011642A3 (cs) Léčivo pro prevenci progrese aterosklerózy u savců
WO2004098505A3 (fr) Attenuation des lesions ischemiques/de reperfusion
DE60005548D1 (de) Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung
BR0312402A (pt) Utilização de inibidores seletivos de ciclooxigenase-2 e agentes trombolìticos para o tratamento ou prevenção de um episódio vaso-oclusivo